Pricing the Centenarian: Longevity Risk as a 40-Year ALM Challenge

As we move deeper into 2026, the institutional investment landscape is confronting an inescapable reality: humans are living longer than legacy financial models predicted. The latest CDC data confirms US life expectancy has hit a record 79.0 years, while Japan continues to set the global benchmark with females at 87.13 years. For global insurance asset managers, this is a primary risk to the structural integrity of Asset-Liability Management (ALM).

The Cost of Living Longer

The funding gap created by longevity is profound. Quantitative research from the IMF suggests that a mere one-year unexpected increase in life expectancy can swell defined-benefit (DB) pension liabilities by 3% to 4%. In a multi-billion dollar plan, this is not a marginal shift — it is a systemic solvency threat.

The Rise of Longevity Risk Transfer (LRT)

The market’s response has been decisive. In 2025, the Longevity Risk Transfer market hit a record volume of over £31 billion, driven by massive swaps in the UK and Netherlands. WTW forecasts the broader UK Pension Risk Transfer (PRT) market could reach £70 billion in 2026. This surge represents a fundamental shift: institutions are no longer willing to carry the “tail risk” of their policyholders outliving their assets.

Engineering the Biological Variable

At Ordefoco Asset Management, we approach longevity with the same engineering mindset I applied to tech architecture. We integrate medical progress and demographic shifts directly into our duration matching. We aren’t just matching cash flows; we are matching extended cash flows. By utilizing Longevity Swaps and alternative credit, we ensure that our capital preservation strategies are as durable as the lives they protect.

Fiduciary duty in 2026 means ensuring the money is there when the promise comes due — no matter how far in the future that may be.

Ordefoco Asset Management: https://www.ordefocoassetmanagement.com/